Klisyri

Active Ingredient(s): Tirbanibulin
FDA Approved: * December 14, 2020
Pharm Company: * ALMIRALL
Category: Skin Care

Tirbanibulin, sold under the brand name Klisyri, is a medication for the treatment of actinic keratosis on the face or scalp.[1][2][3] The most common side effects include local skin reactions, application site pruritus, and application site pain.[1][2] Tirbanibulin was approved for medical use in the United States in December 2020,[2][4][5] and in the European Unio... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Klisyri 10 mg/g Topical Ointment

NDC: 16110-391

Labeler:

Almirall, LLC